{"success":true,"data":{"pressRelease":{"id":"94198","rtpr_id":"nGNX8dXPTn","ticker":"CCRN","exchange":"NASDAQ","all_tickers":["CCRN","DSGR","PSNL"],"title":"BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Personalis, Inc. (Nasdaq – PSNL), Distribution Solutions Group, Inc. (Nasdaq – DSGR), Cross Country Healthcare, Inc. (Nasdaq – CCRN), Nuvalent, Inc. (Nasdaq – NUVL)","author":"Globe Newswire","published_at":"2026-07-21T14:46:32.102Z","article_body":"BALA CYNWYD, Pa., July 21, 2026 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds\ninvestors of the following investigations. If you own shares and wish to\ndiscuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com)\nor Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no\ncost or financial obligation to you.\n\nPersonalis, Inc. (Nasdaq – PSNL)\n\nUnder the terms of the Merger Agreement, Personalis will be acquired by Tempus\nAI, Inc. (Nasdaq - TEM) for $16.25 per share of common stock, representing a\ntotal enterprise value of $1.5 billion, net of Tempus’ existing ownership\ninterest. The investigation concerns whether the Personalis Board breached its\nfiduciary duties to shareholders by failing to conduct a fair process,\nincluding whether the proposed transaction is paying fair value to\nshareholders of the Company.\n\nAdditional information can be found at\nhttps://www.brodskysmith.com/cases/personalis-inc-nasdaq-psnl/.\n\nDistribution Solutions Group, Inc. (Nasdaq – DSGR)\n\nUnder the terms of the Merger Agreement, Distribution Solutions Group will be\nacquired by LKCM Headwater Investments, LLC for $35.00 per share in cash. LKCM\nHeadwater and its affiliates currently own approximately 79% of Distribution\nSolutions Group’s outstanding common stock. J. Bryan King, Distribution\nSolutions Group’s Chairman and Chief Executive Officer, is the Managing\nPartner of LKCM Headwater. The investigation concerns whether the Distribution\nSolutions Group Board breached its fiduciary duties to shareholders by failing\nto conduct a fair process, including whether the proposed transaction is\npaying fair value to shareholders of the Company.\n\nAdditional information can be found at\nhttps://www.brodskysmith.com/cases/distribution-solutions-group-inc-nasdaq-dsgr/.\n\nCross Country Healthcare, Inc. (Nasdaq – CCRN)\n\nUnder the terms of the Merger Agreement, Cross Country Healthcare will be\nacquired by Knox Lane for $13.25 per share in an all-cash transaction valued\nat $437 million. The investigation concerns whether the Cross Country\nHealthcare Board breached its fiduciary duties to shareholders by failing to\nconduct a fair process, including whether the proposed transaction is paying\nfair value to shareholders of the Company.\n\nAdditional information can be found at\nhttps://www.brodskysmith.com/cases/cross-country-healthcare-inc-nasdaq-ccrn-3/.\n\nNuvalent, Inc. (Nasdaq – NUVL)\n\nUnder the terms of the Merger Agreement, Nuvalent will be acquired by GSK plc\n(NYSE - GSK) for $124.00 per share in cash in a deal valued at $10.6 billion.\nThe investigation concerns whether the Nuvalent Board breached its fiduciary\nduties to shareholders by failing to conduct a fair process, including whether\nthe proposed transaction is paying fair value to shareholders of the Company.\n\nAdditional information can be found at\nhttps://www.brodskysmith.com/cases/nuvalent-inc-nasdaq-nuvl/.\n\nDana Incorporated (NYSE – DAN)\n\nUnder the terms of the Merger Agreement, Dana will be acquired by Eaton\nCorporation plc (NYSE - ETN) in a transaction valued at approximately $5.1\nbillion. Eaton shareholders will own at least 50.1% and Dana shareholders\nowning approximately 49.9% of the combined company at close. Eaton will\nreceive a cash distribution of approximately $1.1 billion (subject to\nadjustments for cash and indebtedness). The investigation concerns whether the\nDana Incorporated Board breached its fiduciary duties to shareholders by\nfailing to conduct a fair process, including whether the proposed transaction\nis paying fair value to shareholders of the Company.\n\nAdditional information can be found at\nhttps://www.brodskysmith.com/cases/dana-incorporated-nyse-dan/.\n\nBrodsky & Smith is a litigation law firm with extensive expertise representing\nshareholders throughout the nation in securities and class action lawsuits.\nThe attorneys at Brodsky & Smith have been appointed by numerous courts\nthroughout the country to serve as lead counsel in class actions and have\nsuccessfully recovered millions of dollars for our clients and shareholders.\nAttorney advertising. Prior results do not guarantee a similar outcome.\n\n(https://www.globenewswire.com/NewsRoom/AttachmentNg/aeea7200-7231-49dd-b4ba-ec680464b28c)\n\n\n\nGlobeNewswire, Inc. 2026","article_body_html":"","raw_payload":{"data":{"id":"nGNX8dXPTn","title":"BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Personalis, Inc. (Nasdaq – PSNL), Distribution Solutions Group, Inc. (Nasdaq – DSGR), Cross Country Healthcare, Inc. (Nasdaq – CCRN), Nuvalent, Inc. (Nasdaq – NUVL)","author":"Globe Newswire","ticker":"CCRN","created":"2026-07-21T14:46:32.102Z","tickers":["CCRN","DSGR","PSNL"],"exchange":"NASDAQ","article_body":"BALA CYNWYD, Pa., July 21, 2026 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds\ninvestors of the following investigations. If you own shares and wish to\ndiscuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com)\nor Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no\ncost or financial obligation to you.\n\nPersonalis, Inc. (Nasdaq – PSNL)\n\nUnder the terms of the Merger Agreement, Personalis will be acquired by Tempus\nAI, Inc. (Nasdaq - TEM) for $16.25 per share of common stock, representing a\ntotal enterprise value of $1.5 billion, net of Tempus’ existing ownership\ninterest. The investigation concerns whether the Personalis Board breached its\nfiduciary duties to shareholders by failing to conduct a fair process,\nincluding whether the proposed transaction is paying fair value to\nshareholders of the Company.\n\nAdditional information can be found at\nhttps://www.brodskysmith.com/cases/personalis-inc-nasdaq-psnl/.\n\nDistribution Solutions Group, Inc. (Nasdaq – DSGR)\n\nUnder the terms of the Merger Agreement, Distribution Solutions Group will be\nacquired by LKCM Headwater Investments, LLC for $35.00 per share in cash. LKCM\nHeadwater and its affiliates currently own approximately 79% of Distribution\nSolutions Group’s outstanding common stock. J. Bryan King, Distribution\nSolutions Group’s Chairman and Chief Executive Officer, is the Managing\nPartner of LKCM Headwater. The investigation concerns whether the Distribution\nSolutions Group Board breached its fiduciary duties to shareholders by failing\nto conduct a fair process, including whether the proposed transaction is\npaying fair value to shareholders of the Company.\n\nAdditional information can be found at\nhttps://www.brodskysmith.com/cases/distribution-solutions-group-inc-nasdaq-dsgr/.\n\nCross Country Healthcare, Inc. (Nasdaq – CCRN)\n\nUnder the terms of the Merger Agreement, Cross Country Healthcare will be\nacquired by Knox Lane for $13.25 per share in an all-cash transaction valued\nat $437 million. The investigation concerns whether the Cross Country\nHealthcare Board breached its fiduciary duties to shareholders by failing to\nconduct a fair process, including whether the proposed transaction is paying\nfair value to shareholders of the Company.\n\nAdditional information can be found at\nhttps://www.brodskysmith.com/cases/cross-country-healthcare-inc-nasdaq-ccrn-3/.\n\nNuvalent, Inc. (Nasdaq – NUVL)\n\nUnder the terms of the Merger Agreement, Nuvalent will be acquired by GSK plc\n(NYSE - GSK) for $124.00 per share in cash in a deal valued at $10.6 billion.\nThe investigation concerns whether the Nuvalent Board breached its fiduciary\nduties to shareholders by failing to conduct a fair process, including whether\nthe proposed transaction is paying fair value to shareholders of the Company.\n\nAdditional information can be found at\nhttps://www.brodskysmith.com/cases/nuvalent-inc-nasdaq-nuvl/.\n\nDana Incorporated (NYSE – DAN)\n\nUnder the terms of the Merger Agreement, Dana will be acquired by Eaton\nCorporation plc (NYSE - ETN) in a transaction valued at approximately $5.1\nbillion. Eaton shareholders will own at least 50.1% and Dana shareholders\nowning approximately 49.9% of the combined company at close. Eaton will\nreceive a cash distribution of approximately $1.1 billion (subject to\nadjustments for cash and indebtedness). The investigation concerns whether the\nDana Incorporated Board breached its fiduciary duties to shareholders by\nfailing to conduct a fair process, including whether the proposed transaction\nis paying fair value to shareholders of the Company.\n\nAdditional information can be found at\nhttps://www.brodskysmith.com/cases/dana-incorporated-nyse-dan/.\n\nBrodsky & Smith is a litigation law firm with extensive expertise representing\nshareholders throughout the nation in securities and class action lawsuits.\nThe attorneys at Brodsky & Smith have been appointed by numerous courts\nthroughout the country to serve as lead counsel in class actions and have\nsuccessfully recovered millions of dollars for our clients and shareholders.\nAttorney advertising. Prior results do not guarantee a similar outcome.\n\n(https://www.globenewswire.com/NewsRoom/AttachmentNg/aeea7200-7231-49dd-b4ba-ec680464b28c)\n\n\n\nGlobeNewswire, Inc. 2026"},"type":"article","timestamp":"2026-07-21T14:46:32.15135693Z","server_sent_at_ms":1784645192151},"received_at":"2026-07-21T14:46:32.203Z","source_url":null},"analysis":{"id":"83243","press_release_id":"94198","analysis_json":{"industry":{"label":"Health Care Providers & Services","sector":"Health Care"},"redFlags":[],"eventType":"legal_litigation","narrative":"Brodsky & Smith is investigating Cross Country Healthcare regarding its proposed all-cash acquisition by Knox Lane for $13.25 per share.\n\nThe law firm is examining whether the board breached fiduciary duties in the $437 million transaction.\n\nInvestors are reminded they may contact the firm to discuss their rights with no cost or obligation.","sentiment":"neutral","agentHooks":{"shouldPost":false,"suggestedAngle":"Plaintiff-firm solicitation regarding CCRN acquisition -- suppress."},"keyFigures":{"dealValueUsd":437000000,"offeringPrice":13.25},"quotedText":"","namedEntities":{"people":[{"name":"Jason Brodsky"},{"name":"Marc Ackerman"}],"products":[],"companies":[{"name":"Brodsky & Smith","relationship":"plaintiff law firm"},{"name":"Cross Country Healthcare, Inc.","ticker":"CCRN"},{"name":"Knox Lane","relationship":"acquirer"}],"dollarAmounts":[{"amount":"$13.25","context":"per share acquisition price"},{"amount":"$437 million","context":"transaction value"}]},"materialImpact":{"score":1,"reasoning":"Plaintiff law-firm solicitation issued by Brodsky & Smith regarding a pending M&A transaction. No new corporate disclosure or court certification; standard lead plaintiff deadline reminder."},"tickerRelevance":{"others":[{"ticker":"PSNL","relevance":"mentioned"},{"ticker":"DSGR","relevance":"mentioned"},{"ticker":"NUVL","relevance":"mentioned"},{"ticker":"DAN","relevance":"mentioned"}],"primary":"CCRN"},"globalImportance":15,"audienceRelevance":15,"eventTypeSecondary":[],"importanceComponents":{"tickerTier":"small-mid-cap","eventGravity":"law-firm-solicitation","issuerAuthored":false}},"event_type":"legal_litigation","event_type_secondary":null,"sentiment":"neutral","material_impact_score":1,"narrative":"Brodsky & Smith is investigating Cross Country Healthcare regarding its proposed all-cash acquisition by Knox Lane for $13.25 per share.\n\nThe law firm is examining whether the board breached fiduciary duties in the $437 million transaction.\n\nInvestors are reminded they may contact the firm to discuss their rights with no cost or obligation.","key_figures":{"dealValueUsd":437000000,"offeringPrice":13.25},"named_entities":{"people":[{"name":"Jason Brodsky"},{"name":"Marc Ackerman"}],"products":[],"companies":[{"name":"Brodsky & Smith","relationship":"plaintiff law firm"},{"name":"Cross Country Healthcare, Inc.","ticker":"CCRN"},{"name":"Knox Lane","relationship":"acquirer"}],"dollarAmounts":[{"amount":"$13.25","context":"per share acquisition price"},{"amount":"$437 million","context":"transaction value"}]},"model_name":"glm-4.7","prompt_hash":"sha256:727b4b9429a443af","schema_hash":"sha256:05005c02d9cffac9","created_at":"2026-07-21T18:47:53.101Z","global_importance":15,"audience_relevance":15,"importance_components":{"tickerTier":"small-mid-cap","eventGravity":"law-firm-solicitation","issuerAuthored":false}},"durationMs":120986,"modelName":"glm-4.7"}}